Literature DB >> 8131165

Effects of hepatic artery embolization with Lipiodol and gelatin sponge particles on normal swine liver.

M Sato1, R Yamada, B Uchida, P Hedgepeth, J Rosch.   

Abstract

In order to evaluate the effects of hepatic artery embolization (HAE) with Lipiodol (Lp) and gelatin sponge particles (GSP) on swine liver tissue, we embolized the hepatic arteries of 3 pigs with GSP, 9 with Lp, and 9 with Lp + GSP. None of the pigs embolized with GSP died spontaneously during the 4-week experimental period. One pig embolized with 1 ml/kg Lp and three pigs with 2 ml/kg Lp died within 2 h. Two pigs embolized with 0.5 ml/kg Lp + GSP died the following day. The portal vein pressure (PVP) and wedge hepatic vein pressure (WHVP) values before HAE, immediately after, 1 h after, and 4 weeks after HAE showed no remarkable change in the GSP group. Remarkable and temporary elevation was observed in the more than 0.2 ml/kg Lp group. Remarkable and continuous elevation was observed in the 0.2 ml/kg Lp + GSP and 0.5 ml/kg Lp + GSP groups. Gross and histological studies demonstrated no liver damage in the GSP and Lp group. Liver infarction, circular coagulation necrosis with pseudocapsule, and liver atrophy were found in the Lp + GSP group 4 weeks after HAE. The incidence of infarction, circular coagulation necrosis, and liver atrophy in the livers embolized with 0.2 ml/kg Lp + GSP and 0.5 ml/kg Lp + GSP were 67%, 100%, and 75%, respectively. In conclusion, when the hepatic artery is embolized with Lp + GSP, the volume of Lp should be limited to less than 0.1 ml/kg.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8131165     DOI: 10.1007/bf02603139

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  9 in total

1.  Transcatheter occlusion of abdominal tumors.

Authors:  H M Goldstein; S Wallace; J H Anderson; R L Bree; C Gianturco
Journal:  Radiology       Date:  1976-09       Impact factor: 11.105

2.  Clinical evaluation of hepatic artery embolization: comparison between Gelfoam and Lipiodol with anticancer agent.

Authors:  Y Yamashita; M Takahashi; N Fujimura; M Kan
Journal:  Radiat Med       Date:  1987 May-Jun

3.  Peripheral hepatic arterial embolization with crosslinked collagen fibers.

Authors:  J R Daniels; R K Kerlan; L Dodds; P McLaughlin; J M LaBerge; D Harrington; A M Daniels; E J Ring
Journal:  Invest Radiol       Date:  1987-02       Impact factor: 6.016

4.  [Hepatic, arterial embolization in patients with malignant liver tumours (author's transl)].

Authors:  D Doyon; A Mouzon; A M Jourde; C Regensberg; C Frileux
Journal:  Ann Radiol (Paris)       Date:  1974-10

5.  Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents.

Authors:  K Takayasu; Y Shima; Y Muramatsu; N Moriyama; T Yamada; M Makuuchi; H Hasegawa; S Hirohashi
Journal:  Radiology       Date:  1987-05       Impact factor: 11.105

6.  Hepatocellular carcinoma detected by iodized oil. Use of anticancer agents.

Authors:  H Ohishi; H Uchida; H Yoshimura; S Ohue; J Ueda; M Katsuragi; N Matsuo; Y Hosogi
Journal:  Radiology       Date:  1985-01       Impact factor: 11.105

7.  Therapeutic Ivalon embolization of hepatic tumors.

Authors:  V P Chuang; S Wallace; C S Soo; C Charnsangavej; T Bowers
Journal:  AJR Am J Roentgenol       Date:  1982-02       Impact factor: 3.959

8.  Studies on anticancer treatment with an oily anticancer drug injected into the ligated feeding hepatic artery for liver cancer.

Authors:  K Nakakuma; S Tashiro; T Hiraoka; K Uemura; T Konno; Y Miyauchi; I Yokoyama
Journal:  Cancer       Date:  1983-12-15       Impact factor: 6.860

9.  Therapeutic embolisation of the hepatic artery: a review of 75 procedures.

Authors:  D J Allison; H Jordan; O Hennessy
Journal:  Lancet       Date:  1985-03-16       Impact factor: 79.321

  9 in total
  6 in total

1.  Effect of interval between transcatheter hepatic arterial embolization and radiofrequency ablation on ablated lesion size in a swine model.

Authors:  Cao Guang; Nobuyuki Kawai; Morio Sato; Isao Takasaka; Hiroki Minamiguchi; Shinya Sahara; Kouhei Nakata; Tetsuo Sonomura; Shintaro Shirai; Ichiro Mori; Renjie Yang
Journal:  Jpn J Radiol       Date:  2011-09-29       Impact factor: 2.374

2.  Ablative zone size created by radiofrequency ablation with and without chemoembolization in small hepatocellular carcinomas.

Authors:  Takashi Yamanaka; Koichiro Yamakado; Haruyuki Takaki; Atsuhiro Nakatsuka; Katsuya Shiraki; Hiroshi Hasegawa; Yoshiyuki Takei; Kan Takeda
Journal:  Jpn J Radiol       Date:  2012-05-19       Impact factor: 2.374

3.  Complications of hepatic chemoembolization.

Authors:  Timothy W I Clark
Journal:  Semin Intervent Radiol       Date:  2006-06       Impact factor: 1.513

4.  Liver microcirculation after hepatic artery embolization with degradable starch microspheres in vivo.

Authors:  Jian Wang; Satoru Murata; Tatsuo Kumazaki
Journal:  World J Gastroenterol       Date:  2006-07-14       Impact factor: 5.742

5.  Prospective comparison of transcatheter arterial chemoembolization with Lipiodol-epirubicin and Lipiodol-cisplatin for treatment of recurrent hepatocellular carcinoma.

Authors:  Shinya Sahara; Nobuyuki Kawai; Morio Sato; Hiroki Minamiguchi; Motoki Nakai; Isao Takasaka; Kouhei Nakata; Akira Ikoma; Naohisa Sawa; Tetsuo Sonomura; Shintaro Shirai
Journal:  Jpn J Radiol       Date:  2010-06-30       Impact factor: 2.374

Review 6.  Sequential transarterial chemoembolization for unresectable advanced hepatocellular carcinoma.

Authors:  H J Jaeger; U M Mehring; F Castañeda; F Hasse; G Blumhardt; D Loehlein; K D Mathias
Journal:  Cardiovasc Intervent Radiol       Date:  1996 Nov-Dec       Impact factor: 2.740

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.